The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Regulatory News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

9 Sep 2020 14:05

RNS Number : 5141Y
Amryt Pharma PLC
09 September 2020
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APMFLFIVAEIAIII
Date   Source Headline
24th Apr 20177:00 amRNSFirst Patient Enrolled
10th Apr 20175:21 pmRNSDirector/PDMR Shareholding
6th Apr 20174:13 pmRNSPosting of Annual Report 2016 and Notice of AGM
30th Mar 20177:00 amRNSFinal Results
28th Mar 20177:00 amRNSPhase 3 Clinical Trial for AP101 commenced
27th Mar 20177:00 amRNSSenior Management Appointment
8th Mar 20177:00 amRNSNotice of Results
6th Mar 20177:00 amRNSAP101 trial discussions completed with FDA & EMA
9th Feb 20177:00 amRNSDirectorate Change
7th Feb 20177:00 amRNSGrant of patent in Japan for AP101 (Episalvan)
6th Feb 20177:00 amRNSPre-clinical study results
5th Dec 20167:00 amRNSTransformational Licence Agreement
2nd Dec 20167:00 amRNSEUR20m Facility with European Investment Bank
7th Nov 20167:00 amRNSOrphan drug designation for Acromegaly Compound
19th Sep 20167:00 amRNSAppointment of Chief Medical Officer
13th Sep 20167:00 amRNSHalf-year Report
13th Sep 20167:00 amRNSGrant of US patent for lead drug, Episalvan
7th Jul 201612:54 pmRNSResult of AGM
27th Jun 20167:00 amRNSMarkus Ziener appointed as Non-Executive Director
9th Jun 20167:00 amRNSFinancial Results
2nd Jun 20164:34 pmRNSNotice of Results
21st Apr 20164:35 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSAdmission to trading on AIM and ESM
18th Apr 20162:30 pmRNSESM Schedule 1 Update
18th Apr 20162:30 pmRNSSchedule One update - Fastnet Equity plc
18th Apr 201612:41 pmRNSResult of General Meeting and Change of Name
31st Mar 20167:35 amRNSESM Schedule 1
31st Mar 20167:30 amRNSSchedule One - Fastnet Equity plc
31st Mar 20167:30 amRNSRestoration - Fastnet Equity plc
31st Mar 20167:00 amRNSProposed Acquisition of Amryt Pharmaceuticals
22nd Feb 20167:30 amRNSPotential Acquisition and Statement re Suspension
22nd Feb 20167:30 amRNSSuspension - Fastnet Equity plc
21st Dec 20157:01 amRNSAppointment of Non-executive Director
21st Dec 20157:00 amRNSInterim Results
18th Dec 20157:00 amRNSDemerger of Oil and Gas Assets
30th Sep 20153:12 pmRNSResult of Annual General Meeting
4th Sep 20157:00 amRNSFinal Results
28th Aug 20153:31 pmRNSResult of General Meeting
11th Aug 20153:35 pmRNSProposed adoption of Investing Policy/Notice of GM
3rd Jul 20153:22 pmRNSDirector/PDMR Shareholding
26th Jun 20152:45 pmRNSDirector/PDMR Shareholding
2nd Jun 20152:27 pmRNSHolding(s) in Company
1st Jun 20157:00 amRNSCorporate Update
26th Mar 20157:00 amRNSCeltic Sea Portfolio
27th Jan 201512:56 pmRNSDirectorate Change
9th Jan 201512:49 pmRNSHolding(s) in Company
2nd Jan 20157:00 amRNSExpiry of Tendrara Option Agreement
19th Dec 20147:00 amRNSInterim Results
10th Dec 20147:00 amRNSBoard changes & operational update
1st Dec 20143:00 pmRNSResponse to press speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.